You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Myeloma Proteins

Showing 1 - 25 of 5,342
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in United States (TTI-622, Daratumumab Hyaluronidase-fihj)

Recruiting
  • Multiple Myeloma
  • TTI-622
  • Daratumumab Hyaluronidase-fihj
  • Basking Ridge, New Jersey
  • +6 more
Dec 8, 2022

Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma Trial in Cleveland (Multiple

Not yet recruiting
  • Multiple Myeloma
  • +2 more
  • Multiple Myeloma M-Protein Analysis
  • Multiple Myeloma Knowledge Questionnaires
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Apr 26, 2023

Multiple Myeloma Trial in Hackensack (Bortezomib)

Terminated
Has Results
  • Multiple Myeloma
  • Hackensack, New Jersey
    The Cancer Center at Hackensack University Medical Center
Jun 24, 2022

Smoldering Multiple Myeloma Trial (Selinexor)

Not yet recruiting
  • Smoldering Multiple Myeloma
  • (no location specified)
Oct 27, 2022

Multiple Myeloma Prognostic Indices

Recruiting
  • Multiple Myeloma
  • Hematologic Diseases
  • blood viscosity , albumin / fibrinogen ratio and red cell distribution
  • Assiut, Egypt
    Assiut University hospital
Oct 17, 2023

Recurrent Plasma Cell Myeloma Trial in Jacksonville (Dexamethasone, Laboratory Biomarker Analysis, Lenalidomide)

Active, not recruiting
  • Recurrent Plasma Cell Myeloma
  • Jacksonville, Florida
    Mayo Clinic in Florida
Jan 4, 2023

Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial (Venetoclax)

Not yet recruiting
  • Multiple Myeloma in Relapse
  • Multiple Myeloma, Refractory
  • (no location specified)
Oct 30, 2023

Relapsed Cancer, Refractory Multiple Myeloma, Multiple Myeloma Trial in Boston (Isatuximab, Belantamab mafodotin, Pomalidomide)

Not yet recruiting
  • Relapsed Cancer
  • +2 more
  • Boston, Massachusetts
  • +1 more
Jun 19, 2023

Healthy Volunteers of Fanconi Anemia, Myeloproliferative

Completed
  • Chronic Myeloproliferative Disorders
  • +3 more
  • microarray analysis
  • +8 more
  • Portland, Oregon
    Knight Cancer Institute at Oregon Health and Science University
Jun 30, 2022

Monoclonal Gammopathies, Multiple Myeloma, M-protein Trial in Guangzhou (Observational studies, no intervention)

Recruiting
  • Monoclonal Gammopathies
  • +2 more
  • Observational studies, no intervention
  • Guangzhou, Guangdong, China
    Zhujiang Hospital of Southern Medical University
Jan 6, 2023

Cancer Prevention, Weight Loss, Smoldering Waldenstrom Macroglobulinemia(WM) Trial in Boston (Prolonged Fasting Intervention,

Not yet recruiting
  • Cancer Prevention
  • +5 more
  • Prolonged Fasting Intervention
  • EDUCATION CONTROL
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Dec 28, 2022

Multiple Myeloma, Multiple Myeloma in Relapse Trial in Boston (Ixazomib, Pomalidomide, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Multiple Myeloma in Relapse
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Apr 13, 2022

Multiple Myeloma Trial in Zhengzhou, Wuhan, Xi'an (Selinexor (80mg/d), Selinexor (100mg/d), Pegylated liposomal doxorubicin)

Recruiting
  • Multiple Myeloma
  • Selinexor (80mg/d)
  • +4 more
  • Zhengzhou, Henan, China
  • +4 more
Aug 16, 2022

Multiple Myeloma Trial in Worldwide (Talquetamab, Teclistamab, Daratumumab)

Recruiting
  • Multiple Myeloma
  • Edmonton, Alberta, Canada
  • +12 more
Jan 27, 2023

Selinexor in Relapsed or Refractory Multiple Myeloma - SEATTLE-

Recruiting
  • Multiple Myeloma
  • Wien, Austria
  • +1 more
Jul 13, 2023

Multiple Myeloma Trial in Tampa (biological, procedure, drug)

Active, not recruiting
  • Multiple Myeloma
  • Survivin Vaccine
  • +3 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 7, 2022

Smoldering Multiple Myeloma Trial in Boston (Ixazomib, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Smoldering Multiple Myeloma
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Mar 15, 2022

Multiple Myeloma Trial in Worldwide (Bortezomib, Dexamethasone, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • San Francisco, California
  • +152 more
Jan 27, 2023

Effect of SARS-CoV-2 Vaccination in Liver Transplant Recipients

Completed
  • SARS-CoV-2 Vaccination
  • Liver Transplantation
  • Immunoassay, by ECLIA, for the quantitative in vitro determination of antibodies (including IgG) to the SARS - CoV - 2 spike protein (S) anti-RBD (receptor-binding domain) in serum and plasma samples.
  • Roma, Italy
    Policlinico Tor Vergata
Aug 3, 2022

Multiple Myeloma Trial in Shanghai (Selinexor, Thalidomide, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Shanghai, Shanghai, China
    Shanghai Changzheng Hospital
Mar 3, 2022

Multiple Myeloma Trial in United States (ACY-1215, lenalidomide, Dexamethasone)

Completed
  • Multiple Myeloma
  • Boston, Massachusetts
  • +4 more
Feb 7, 2022

Multiple Myeloma Trial in Charlottesville (SLAMF7 BATs)

Not yet recruiting
  • Multiple Myeloma
  • SLAMF7 BATs
  • Charlottesville, Virginia
    University of Virginia
May 17, 2022

Multiple Myeloma Trial in Guangzhou (Selinexor, Bortezomib, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Guangzhou, Guangdong, China
  • +3 more
Aug 16, 2022

Relapsed Multiple Myeloma, Refractory Multiple Myeloma Trial (Elotuzumab, Selinexor, and Dexamethasone (ESd))

Withdrawn
  • Relapsed Multiple Myeloma
  • Refractory Multiple Myeloma
  • Elotuzumab, Selinexor, and Dexamethasone (ESd)
  • (no location specified)
Apr 27, 2022

Multiple Myeloma Trial in Ann Arbor (Iodine I 131 Tositumomab)

Active, not recruiting
Has Results
  • Multiple Myeloma
  • Iodine I 131 Tositumomab
  • Ann Arbor, Michigan
    University of Michigan
Mar 16, 2022